Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	DrugBank	Drug (Description in trials)	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Cemdisiran	[1] Cemdisiran;	-	-	-	[2] 66, 109 💬
2	Eculizumab	[7] Abp 959 - biosimilar to eculizumab; Abp 959 - proposed biosimilar to eculizumab; Eculizumab; Other: blood collection for measurement of eculizumab peak concentrations; Other: eculizumab; Sb12 (proposed eculizumab biosimilar); Soliris (eculizumab);	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[8] 11, 13, 14, 61, 62, 109, 222, 223 💬
3	Narsoplimab	[2] Narsoplimab; Oms721 (narsoplimab);	[1] D11531 💬	[1] MASP2 💬	[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection	[5] 64, 66, 109, 222, 223 💬
4	Nomacopan	-	[1] D11473 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[2] 62, 109 💬
5	Ravulizumab	[1] Ravulizumab;	[1] D11054 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[5]  2 , 11, 13, 62, 109 💬